ASBP News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-19 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-08-10 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,2.03,3.02,7.01,9.01. |
| 2026-07-20 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01. |
| 2026-06-22 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.07. |
| 2026-06-12 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,7.01,9.01. |
| 2026-06-12 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01. |
| 2026-05-14 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.03,9.01. |
| 2026-04-20 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-04-17 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K/A | Aspire Biopharma Holdings, Inc. filed Form 8-K/A covering items 1.01,5.03,9.01. |
| 2026-04-16 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-04-16 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.07. |
| 2026-04-16 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,5.03,9.01. |
| 2026-04-15 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01. |
| 2026-02-12 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,3.02,5.02,7.01,9.01. |
| 2026-02-06 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.03,9.01. |
| 2026-01-30 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,3.02,9.01. |
| 2026-01-15 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2026-01-13 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.02. |
| 2026-01-06 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,3.02,9.01. |
| 2025-11-14 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,1.02,2.03,3.02,9.01. |
| 2025-11-05 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.07. |
| 2025-10-17 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 3.01,9.01. |
| 2025-09-26 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 3.02,4.01,9.01. |
| 2025-08-22 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2025-07-30 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.02,9.01. |
| 2025-06-18 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2025-06-10 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2025-04-30 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2025-04-18 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 3.01,9.01. |
| 2025-02-21 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,2.01,2.03,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,9.01. |
| 2025-02-20 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,2.03,3.02,7.01,9.01. |
| 2025-02-10 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.07,8.01,9.01. |
| 2024-12-26 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,3.02,9.01. |
| 2024-10-10 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-10-04 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-09-06 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-09-03 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2024-08-30 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-07-23 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.02,9.01. |
| 2024-06-07 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-05-28 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.03,5.07,9.01. |
| 2024-05-22 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-05-20 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,8.01,9.01. |
| 2024-05-16 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2023-12-28 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,2.03,7.01,9.01. |
| 2023-08-23 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,5.02,8.01,9.01. |
| 2023-08-14 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01. |
| 2023-07-19 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2023-05-24 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K/A | Aspire Biopharma Holdings, Inc. filed Form 8-K/A covering items 5.07. |
| 2023-05-23 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.03,5.07,8.01,9.01. |
| 2023-05-15 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2023-05-09 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2023-05-04 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01. |
| 2023-05-01 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,9.01. |
| 2022-05-19 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 5.02. |
| 2022-04-08 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2022-03-01 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 8.01,9.01. |
| 2022-02-23 | Current report | SEC filing | Aspire Biopharma Holdings, Inc. filed Form 8-K | Aspire Biopharma Holdings, Inc. filed Form 8-K covering items 1.01,3.02,8.01,9.01. |